April 6, 2011

Robert J. Easton to Serve as Panelist at the NYBA 20th Annual Meeting

At the New York Biotechnology Association’s 20th Annual Meeting on April 6-7, 2011, Robert J. Easton will participate in two panels entitled “From Kickoff to Closing: Taking Steps to Sell or Go Public” and “Progress in Autoimmune Disorders.”

From Kickoff to Closing: Taking Steps to Sell or Go Public
Panel Abstract: This panel will discuss how life sciences companies preparing to go public or put themselves up for sale need to plan at least one year, and sometimes more, in advance. While several steps will overlap as they will be relevant to both the IPO process and the company sale process, some steps will be more relevant to a sale or an IPO. Another form of going public to be discussed is the utilization of a reverse merger with a public shell corporation, enabling the company to enter the capital market quickly and provide an exit strategy for the private company investors. We will explore the state of the IPO, reverse merger, and sale markets and consider and prioritize the steps that should be taken to best prepare for these eventualities.

Panel:

Mintz Levin
Joel Papernik, Partner, Mintz Levin

Scisive Consulting
Robert J. Easton, Chairman, Scisive Consulting

Cyclacel Pharmaceuticals, Inc.
Spiro Rombotis, President & CEO, Cyclacel Pharmaceuticals, Inc.

Lazard Freres & Co.
Jason R. Bernhard, Managing Director, Lazard Freres & Co.


Progress in Autoimmune Disorders
Panel Abstract: Autoimmune diseases arise from an overactive immune response against substances and tissues normally present in the body. In other words, the body actually attacks its own cells. Join us for this featured session looking at the state of the art, and the future, of therapies for autoimmune diseases.

Panel:

NYU School of Medicine
Jeffrey Greenberg, MD, Associate Director, Clinical & Translational Sciences, NYU School of Medicine

Kadmon Pharmaceuticals
Samuel D. Waksal, PhD, CEO & Founder, Kadmon Pharmaceuticals

NYU Langone Medical Center
Jonathan Samuels, MD, Assistant Professor, Department of Rheumatology, NYU Langone Medical Center

Scisive Consulting
Robert J. Easton, Chairman, Scisive Consulting